Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis.

Lu YY, Chen JH, Lin WY, Liang JA, Wang HY, Tsai SC, Kao CH.

Clin Nucl Med. 2012 Sep;37(9):833-7. doi: 10.1097/RLU.0b013e31825b2071. Review.

PMID:
22889770
2.

18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.

Lu YY, Chen JH, Liang JA, Chu S, Lin WY, Kao CH.

Nucl Med Commun. 2014 Jul;35(7):697-703. doi: 10.1097/MNM.0000000000000122. Review.

PMID:
24694775
3.

18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

Cheng X, Li Y, Liu B, Xu Z, Bao L, Wang J.

Acta Radiol. 2012 Jul;53(6):615-27. doi: 10.1258/ar.2012.110603. Epub 2012 Jun 25.

PMID:
22734080
4.

Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.

Lu YY, Chen JH, Chien CR, Chen WT, Tsai SC, Lin WY, Kao CH.

Int J Colorectal Dis. 2013 Aug;28(8):1039-47. doi: 10.1007/s00384-013-1659-z. Epub 2013 Feb 14. Review.

PMID:
23407908
5.

Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.

Acad Radiol. 2014 Jan;21(1):11-20. doi: 10.1016/j.acra.2013.09.015. Review.

PMID:
24331260
6.

A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.

Lu YY, Chen JH, Ding HJ, Chien CR, Lin WY, Kao CH.

Nucl Med Commun. 2012 Nov;33(11):1127-33. Review.

PMID:
23000829
7.

Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.

Tirumani SH, Sakellis C, Jacene H, Shinagare AB, Munshi NC, Ramaiya NH, Van den Abbeele AD.

Clin Nucl Med. 2016 Jan;41(1):e7-13. doi: 10.1097/RLU.0000000000000902.

PMID:
26252323
8.

A systematic review of MRI, scintigraphy, FDG-PET and PET/CT for diagnosis of multiple myeloma related bone disease--which is best?

Weng WW, Dong MJ, Zhang J, Yang J, Xu Q, Zhu YJ, Liu NH.

Asian Pac J Cancer Prev. 2014;15(22):9879-84. Review.

9.

18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation.

Derlin T, Weber C, Habermann CR, Herrmann J, Wisotzki C, Ayuk F, Wolschke C, Klutmann S, Kröger N.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):493-500. doi: 10.1007/s00259-011-1993-8. Epub 2011 Nov 24.

PMID:
22113619
10.

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

Nanni C, Zamagni E, Versari A, Chauvie S, Bianchi A, Rensi M, Bellò M, Rambaldi I, Gallamini A, Patriarca F, Gay F, Gamberi B, Cavo M, Fanti S.

Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.

PMID:
26475305
11.

Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis.

Zhang L, Wang Y, Lei J, Tian J, Zhai Y.

Acta Radiol. 2013 Sep;54(7):770-7. doi: 10.1177/0284185113481594. Epub 2013 Apr 30.

PMID:
23528566
12.

18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.

Wu LM, Hu JN, Hua J, Gu HY, Zhu J, Xu JR.

J Gastroenterol Hepatol. 2012 Mar;27(3):472-80. doi: 10.1111/j.1440-1746.2011.06919.x. Review.

PMID:
21916986
13.

Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.

Chu Y, Zheng A, Wang F, Lin W, Yang X, Han L, Chen Y, Bai L.

Nucl Med Commun. 2014 Feb;35(2):144-50. doi: 10.1097/MNM.0000000000000026. Review.

PMID:
24177043
14.

Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.

Chang MC, Chen JH, Liang JA, Lin CC, Yang KT, Cheng KY, Yeh JJ, Kao CH.

Acad Radiol. 2012 Mar;19(3):349-57. doi: 10.1016/j.acra.2011.10.018. Epub 2011 Dec 14. Review.

PMID:
22173321
15.

Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.

Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.

Int J Cancer. 2013 Jan 15;132(2):E37-47. doi: 10.1002/ijc.27779. Epub 2012 Sep 1.

16.

Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Prior JO, Bertagna F, Ceriani L, Giovanella L.

Lung Cancer. 2014 Jan;83(1):1-7. doi: 10.1016/j.lungcan.2013.11.002. Epub 2013 Nov 13. Review.

PMID:
24290256
17.
18.

(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.

Sachpekidis C, Mai EK, Goldschmidt H, Hillengass J, Hose D, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A.

Clin Nucl Med. 2015 Jun;40(6):e300-7. doi: 10.1097/RLU.0000000000000773.

PMID:
25783508
19.

Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Zakavi SR, Caldarella C, Muoio B, Bertagna F, Ceriani L, Giovanella L.

Foot (Edinb). 2013 Dec;23(4):140-8. doi: 10.1016/j.foot.2013.07.002. Epub 2013 Jul 29. Review.

PMID:
23906976
20.

Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for detecting bladder lesions? A meta-analysis of the literature.

Wang N, Jiang P, Lu Y.

Urol Int. 2014;92(2):143-9. doi: 10.1159/000351964. Epub 2013 Aug 8.

PMID:
23941766

Supplemental Content

Support Center